Overview
Beond is a for-profit ibogaine provider operating in Cancún, Quintana Roo, Mexico. Its own published material describes medically supervised ibogaine treatment delivered with hospital-grade clinical care for people seeking help with opioid and other substance dependence, depression and trauma[1]. The clinic is listed alongside other Mexican providers in third-party treatment directories[2]. This page describes the provider and the context around it; it is not an endorsement, a referral or a safety assessment, and this wiki has no relationship with the clinic.
Background on the substance itself is on the main ibogaine article, with related pages on ibogaine treatment in Mexico and ibogaine treatment centers.
Name and spelling
The company spells its name Beond. The variant Beyond Ibogaine is common in search traffic and on third-party pages, and both spellings are used by sites that write about the Cancún program[12][13]. Readers comparing providers should note that similarly named websites are not always operated by the clinic itself; only material published on the company''s own domain can be treated as its own statement[1].
Program structure
Beond''s published description centers on a residential, medically supervised stay in Cancún with pre-treatment screening, supervised dosing and post-dose observation[1]. Third-party pages covering the Cancún program describe a comparable multi-day structure — intake and medical work-up, a dosing day, then several days of rest and integration before travel home[12][14][15]. That pattern matches how the wider ibogaine treatment subculture has been documented in the academic literature[10]. Observational studies of opioid detoxification in clinic settings describe a single high dose given under cardiac monitoring, with withdrawal typically assessed over the following days[4][6].
Reported costs
Prices for ibogaine programs in Mexico are published inconsistently and change often. A treatment directory covering Mexican ibogaine providers lists a wide price range across clinics[2], and cost-focused third-party sites describe totals that vary with program length, medical staffing, accommodation and aftercare[14][16]. Because ibogaine is unapproved, costs are paid privately and are not reimbursed by insurance. Prospective patients should confirm current pricing and what it includes directly with the provider.
Legal and regulatory context in Mexico
Ibogaine is not a scheduled controlled substance in Mexico and is not an approved medicine there, which is why an unregulated treatment sector has grown in Mexican border and resort cities while the drug remains Schedule I in the United States[10][9]. Unregulated status means facilities are not licensed as ibogaine treatment centers by a national medicines regulator, and standards therefore differ between providers rather than being set centrally[10]. Country-by-country detail is on the ibogaine legality page.
Evidence base
Evidence for ibogaine in substance use disorders comes mainly from open-label and retrospective work. A twelve-month follow-up study of people treated for opioid dependence reported sustained reductions in use in a subset of participants[5]; a detoxification outcomes study reported large short-term drops in withdrawal severity and craving[4]; and an open-label safety study in opioid-dependent participants documented both effects and adverse events under monitoring[6]. In trauma and brain injury, the most-cited study is a 2024 Nature Medicine open-label trial of magnesium–ibogaine in 30 veterans, reported with Stanford investigators[3][7]. None of these are randomized controlled trials, and none were conducted at this clinic.
Safety and screening
Ibogaine prolongs the cardiac QT interval and can precipitate torsades de pointes and cardiac arrest[8]. A systematic review of adverse events in humans records cardiac, neurological and gastrointestinal effects along with deaths, concentrated in poorly monitored settings[9]. Accepted precautions include a baseline electrocardiogram, correction of magnesium and potassium, liver function testing, review of QT-prolonging and interacting medications, and continuous cardiac monitoring through dosing and recovery[3][6]. Anyone considering treatment should ask which of these are performed on site, by whom, and what emergency capability is available.
How to read clinic claims
- Claims about licensing, staffing and monitoring come from the provider unless independently verified[1].
- Success rates quoted by clinics are not trial results; published outcome data are observational and uncontrolled[4][5].
- Relapse after detoxification is common without continuing aftercare[5][11].
- Many sites carrying the clinic''s name are marketing or affiliate pages rather than the clinic''s own publications[12][13].
Further reading
- Beond — Ibogaine Treatment in Cancun, Mexico — beondibogaine.com (the provider''s own site)
- Beyond Mexico Ibogaine — beyondibogainemexico.com
- B